Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10M Buy
191,512
+13,519
+8% +$715K 0.08% 202
2026
Q1
$9.82M Buy
177,993
+33,462
+23% +$1.81M 0.1% 180
2025
Q4
$7.09M Buy
144,531
+28,324
+24% +$1.32M 0.08% 207
2025
Q3
$5.02M Sell
116,207
-33,949
-23% -$1.33M 0.06% 239
2025
Q2
$5.77M Buy
150,156
+3,505
+2% +$134K 0.05% 291
2025
Q1
$5.68M Sell
146,651
-10,645
-7% -$390K 0.06% 283
2024
Q4
$5.32M Sell
157,296
-31,812
-17% -$1.15M 0.05% 281
2024
Q3
$7.73M Sell
189,108
-6,259
-3% -$256K 0.08% 212
2024
Q2
$7.52M Buy
195,367
+14,202
+8% +$597K 0.09% 205
2024
Q1
$7.77M Buy
181,165
+39,751
+28% +$1.64M 0.1% 203
2023
Q4
$5.24M Buy
141,414
+23,578
+20% +$846K 0.08% 248
2023
Q3
$4.27M Buy
+117,836
New +$4.18M 0.07% 252

Other funds holding GSK